1
Clinical Trials associated with Rabies Vaccine for Human Use with CpG adjuvant (Vero cell)(Changchun Zhuoyi Biological) / Not yet recruitingPhase 1 单中心、随机、盲法、对照设计评价不同程序和剂量的试验疫苗在18-60岁人群中接种的安全性和耐受性的Ⅰ期临床试验
[Translation] A single-center, randomized, blinded, controlled phase I clinical trial evaluating the safety and tolerability of different procedures and doses of the experimental vaccine in a population aged 18-60 years.
在18-60岁人群中评价不同剂量试验疫苗的3剂(0、3、7天)和4剂(0、3、7、14天)免疫程序的安全性和耐受性,并探索免疫原性。
[Translation] To evaluate the safety and tolerability of 3-dose (0, 3, 7 days) and 4-dose (0, 3, 7, 14 days) immunization schedules of different doses of the experimental vaccine in a population aged 18–60 years, and to explore immunogenicity.
100 Clinical Results associated with Rabies Vaccine for Human Use with CpG adjuvant (Vero cell)(Changchun Zhuoyi Biological)
100 Translational Medicine associated with Rabies Vaccine for Human Use with CpG adjuvant (Vero cell)(Changchun Zhuoyi Biological)
100 Patents (Medical) associated with Rabies Vaccine for Human Use with CpG adjuvant (Vero cell)(Changchun Zhuoyi Biological)
100 Deals associated with Rabies Vaccine for Human Use with CpG adjuvant (Vero cell)(Changchun Zhuoyi Biological)